Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Emergent BioSolutions Inc.

NYSE: EBS · Life Sciences · 7 alerts · CIK 1367644

Share price
$5.81Close, Nov 16
Market cap
$299M
Shares outstanding
51.42MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Emergent BioSolutions Inc. filings on SEC EDGAR ↗

4:08 PM ET 8-K
Contract Win

Emergent BioSolutions Wins $22.3M Contract from U.S. Department of War

Emergent BioSolutions received a $22.3 million modification exercising an option under an existing IDIQ contract to supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of War. Deliveries will begin in 2026 with a $7.4 million initial shipment and continue through 2027 to support anthrax pre-exposure prophylaxis for all branches of the U.S. military.

Value
$22.3M
Counterparty
U.S. Department of War
Term
through 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.